Nanjing Sinolife United Co Ltd
03332
Company Profile
Business description
Nanjing Sinolife United Co Ltd is a company based in China, predominantly engaged in producing and selling nutritional supplements and the trading of packaged health food products. Its product offerings include Zhongsheng Coenzyme capsules, Guishi Weisi capsules, and Green Zhi capsules, among others. Geographically, the company generates a majority of its revenue from Mainland China, and the rest from New Zealand, Australia, Vietnam, and other countries.
Contact
3 Qingma Road
4th Floor, Building 3
Qixia District
Jiangsu Province
Nanjing
CHNT: +86 2586819188
Sector
Consumer Defensive
Stock type
Defensive
Industry
Packaged Foods
Fiscal Year End
31 December 2025
Employees
477
Stocks News & Analysis
stocks
Strong result for ASX insurer but not the new norm
Stellar first half profits but increasing competition will lower future rate increases.
stocks
Eli Lilly earnings: Weak Orforglipron obesity data weighs down a strong quarter
With today’s share drop, we think Lilly stock looks fairly valued.
stocks
Solid 2025 for A-REIT but development activity will weigh on 2026
Positive news for income investors as yield exceeds 5%.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,107.80 | 31.20 | 0.34% |
| CAC 40 | 7,743.00 | 33.68 | 0.44% |
| DAX 40 | 24,162.86 | 29.64 | -0.12% |
| Dow JONES (US) | 44,175.61 | 206.97 | 0.47% |
| FTSE 100 | 9,095.73 | 5.04 | -0.06% |
| HKSE | 24,906.90 | 48.08 | 0.19% |
| NASDAQ | 21,450.02 | 207.32 | 0.98% |
| Nikkei 225 | 41,820.48 | 761.33 | 1.85% |
| NZX 50 Index | 12,900.94 | 56.31 | 0.44% |
| S&P 500 | 6,389.45 | 49.45 | 0.78% |
| S&P/ASX 200 | 8,837.30 | 30.20 | 0.34% |
| SSE Composite Index | 3,653.50 | 18.37 | 0.51% |